# N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver Disease

> **NCT05589584** · PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 60 (actual)

## Conditions studied

- Simple Steatosis Non Fatty Liver

## Interventions

- **DRUG:** N acetyl cysteine with weight reduction

## Key facts

- **NCT ID:** NCT05589584
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-01
- **Primary completion:** 2024-05-20
- **Final completion:** 2024-08-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589584, "N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05589584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*